| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FCX | Common Stock | Sale | -$2.78M | -54.8K | -1.48% | $50.78 | 3.65M | May 6, 2024 | Direct | F1, F2, F3 |
| holding | FCX | Common Stock | 192K | May 6, 2024 | By IRA | ||||||
| holding | FCX | Common Stock | 1.62M | May 6, 2024 | Through GRATs |
| Id | Content |
|---|---|
| F1 | On April 29, 2024, the Reporting Person exercised stock options that were set to expire in February 2025. Following the sales reported on this Form 4 and the Form 4 filed on May 1, 2024, he has sold 224,000 shares after netting 224,378 shares from the option exercise. |
| F2 | The price reported represents the weighted average price of the shares sold. Shares were sold at varying prices in the range of $50.5700 - $50.9700. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| F3 | Amount beneficially owned includes 1,149,333 RSUs, 1,000,000 of which are vested but deferred. |